{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T08:39:00.656417+00:00","company":{"ticker":"BLGO","cik":880242,"company_name":"BIOLARGO, INC."},"pagination":{"limit":100,"returned":1,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"d329b1b22916c2d724db1cec802fbe908407b09b","cik":880242,"ticker":"BLGO","company_name":"BIOLARGO, INC.","filed_at":"2026-03-25T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"CLEARTHINK CAPITAL PARTNERS, LLC","effective_date":"2026-03-20","item_codes_triggered":["1.01"],"value_text":"up to $10.0 million"},"claim":"BIOLARGO, INC. entered into Purchase Agreement with CLEARTHINK CAPITAL PARTNERS, LLC valued at up to $10.0 million (effective 2026-03-20).","evidence_excerpt":"On March 20, 2026, BioLargo, Inc. (the “Company” or “we”) entered into a purchase agreement dated as of March 20, 2026 (the “Purchase Agreement”), and a registration rights agreement dated as of March 20, 2026 (the “Registration Rights Agreement”), with CLEARTHINK CAPITAL PARTNERS, LLC (“Clearthink”), pursuant to which Clearthink has committed to purchase up to $10.0 million of the Company’s common stock","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-009813","anchor_url":"https://secwatch.observer/filing/0001437749-26-009813#claim-d329b1b22916c2d724db1cec802fbe908407b09b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/880242/000143774926009813/0001437749-26-009813-index.htm"}]}